Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
LipoKnoxa™ Human ACACA shRNA Ad5 Particle (Silencing)
Cat. No.:
V0126XX96
Species:
Human
Target Gene:
ACACA
Vector System:
Adenovirus
Modulation Type:
Silencing (shRNA)
SPECIFIC INQUIRY
Add to basket
| Sub Cat. No. | TargetSeq | Region | Inquiry |
|---|---|---|---|
| V0126XX96-1 | GTATGTTCGAAGGGCTTATAT | CDS | Inquiry |
| V0126XX96-2 | GAATCCTCATTGGCCTATAAT | CDS | Inquiry |
| V0126XX96-3 | TACAAGGGATACAGGTATTTA | CDS | Inquiry |
| V0126XX96-4 | Other | Inquiry |
Product Overview
Description:
LipoKnoxa™ Human ACACA shRNA Ad5 Particle (Silencing) targets ACACA, the rate-limiting enzyme in the biogenesis of long-chain fatty acids. By reducing ACACA expression through customizable shRNA architectures, researchers can evaluate its role in fat accumulation and fatty acid oxidation. All particles are screened through exhaustive quality control—including functional titer, sterility, and mycoplasma detection—to ensure the highest standards of biosafety.
Production Cell Line:
HEK293
Viral Backbone:
Adenovirus type 5 (dE1/E3)
Promoter:
U6; CMV; EF1α; CAG; UBC
Product Availability:
Produced Upon Order
Specification
Titer Test:
qPCR
Insert Verification:
All viral preparations are validated via Sequencing and PCR to ensure 100% sequence identity and the structural integrity of the vector genomes.
Sterility Test:
This product has been certified sterile following comprehensive microbial growth analysis, confirming the absence of bacterial and fungal contamination.
Mycoplasma Test:
This product was certified negative for mycoplasma contamination following stringent QC analysis, ensuring the absence of all mycoplasmal agents.
Other QC:
Beyond standard protocols, we offer customized knockdown efficiency validation through in vitro and in vivo assessments. This includes precise analysis of mRNA/protein reduction and subsequent biological responses to ensure the functional potency of the shRNA-mediated gene silencing.
Storage:
Upon receipt, viral preparations should be immediately transferred to -80°C for long-term storage to ensure maximum stability and maintain product integrity.
Stability:
This product maintains excellent biological activity for 6–12 months (and up to 2 years in specific cases) when stored continuously at -80°C. Once thawed, the working solution remains stable for 2–3 weeks at 4°C without significant loss of viral potency.
Shipping Condition:
All viral preparations are shipped on dry ice to ensure maximum biological activity and stability during transit.
Handling Notes:
Viral particles are susceptible to temperature fluctuations and freeze-thaw cycles. To preserve functional titers, it is essential to aliquot the vector into low-protein-binding tubes immediately upon first thaw. To ensure experimental success and biological safety, all procedures must be conducted within a certified biosafety cabinet.
Intended Use:
This product is intended for research use only and is not for use in diagnosis or therapeutic applications.
Product Disclaimer:
While our products are committed to excellence through rigorous internal QC inspections, we cannot guarantee specific performance or experimental outcomes due to the inherent complexity of biological systems. Users assume full responsibility for product storage, handling, and strict compliance with all applicable safety protocols, biosafety requirements, and legal regulations during all operational processes.
Target Profile
Gene Name:
ACACA
Full Name:
Acetyl-CoA carboxylase alpha
Gene Symbol:
ACC; ACAC; ACC1; ACCA; Acac1; hACC1; ACACAD; ACCalpha; ACACalpha
Gene ID:
31
RefSeq ID-1:
NP_942131.1
RefSeq ID-2:
NM_198834.3
Summary:
ACACA produces the enzyme responsible for the rate-limiting step in de novo fatty acid synthesis. It converts acetyl-CoA into malonyl-CoA, providing the building blocks for long-chain fatty acids. ACACA is highly expressed in lipogenic tissues like fat and liver. It is regulated by "energy sensors" in the cell; for example, it is turned off by phosphorylation when cellular energy is low, making it a central control point for body fat accumulation.
Related Products
-
AdipoUpX™ Human AKT1 Ad5 Particle (Overexpression)
-
LipoKnoxa™ Human ADIPOQ shRNA Ad5 Particle (Silencing)
-
LipoKnoxa™ Human MCHR1 shRNA Ad5 Particle (Silencing)
-
LipoKnoxa™ Human PHB1 shRNA Ad5 Particle (Silencing)
-
AdipoUpX™ Human LCAT Ad5 Particle (Overexpression)
-
AdipoUpX™ Human TCF7L2 Ad5 Particle (Overexpression)